121 related articles for article (PubMed ID: 25999793)
1. HOXB5 Promotes the Proliferation and Invasion of Breast Cancer Cells.
Lee JY; Hur H; Yun HJ; Kim Y; Yang S; Kim SI; Kim MH
Int J Biol Sci; 2015; 11(6):701-11. PubMed ID: 25999793
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional activation of EGFR by HOXB5 and its role in breast cancer cell invasion.
Lee JY; Kim JM; Jeong DS; Kim MH
Biochem Biophys Res Commun; 2018 Sep; 503(4):2924-2930. PubMed ID: 30115380
[TBL] [Abstract][Full Text] [Related]
3. HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
Li ZX; Wu G; Jiang WJ; Li J; Wang YY; Ju XM; Yin YT
Cell Cycle; 2020 Jan; 19(2):233-245. PubMed ID: 31876226
[No Abstract] [Full Text] [Related]
4. HOXB5 promotes proliferation, migration, and invasion of pancreatic cancer cell through the activation of the GSK3β/β-catenin pathway.
Gao Y; Fei X; Kong L; Tan X
Anticancer Drugs; 2020 Sep; 31(8):828-835. PubMed ID: 32796404
[TBL] [Abstract][Full Text] [Related]
5. HOXB5 induces invasion and migration through direct transcriptional up-regulation of β-catenin in human gastric carcinoma.
Hong CS; Jeong O; Piao Z; Guo C; Jung MR; Choi C; Park YK
Biochem J; 2015 Dec; 472(3):393-403. PubMed ID: 26467157
[TBL] [Abstract][Full Text] [Related]
6. HOXB5 Confers Tamoxifen Resistance in Breast Cancer Cells and Promotes Tumor Aggression and Progression.
Kim CY; Kim YC; Oh JH; Kim MH
Anticancer Res; 2021 Jul; 41(7):3409-3417. PubMed ID: 34230136
[TBL] [Abstract][Full Text] [Related]
7. HOXB5 promotes the progression of breast cancer through wnt/beta-catenin pathway.
Zhang J; Zhang S; Li X; Zhang F; Zhao L
Pathol Res Pract; 2021 Aug; 224():153117. PubMed ID: 34118725
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
9. The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells.
Heubach J; Monsior J; Deenen R; Niegisch G; Szarvas T; Niedworok C; Schulz WA; Hoffmann MJ
Mol Cancer; 2015 May; 14():108. PubMed ID: 25994132
[TBL] [Abstract][Full Text] [Related]
10. HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition.
Wu X; Chen H; Parker B; Rubin E; Zhu T; Lee JS; Argani P; Sukumar S
Cancer Res; 2006 Oct; 66(19):9527-34. PubMed ID: 17018609
[TBL] [Abstract][Full Text] [Related]
11. Testes-specific protease 50 promotes cell invasion and metastasis by increasing NF-kappaB-dependent matrix metalloproteinase-9 expression.
Song ZB; Ni JS; Wu P; Bao YL; Liu T; Li M; Fan C; Zhang WJ; Sun LG; Huang YX; Li YX
Cell Death Dis; 2015 Mar; 6(3):e1703. PubMed ID: 25811800
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
Tanaka M; Ichikawa-Tomikawa N; Shishito N; Nishiura K; Miura T; Hozumi A; Chiba H; Yoshida S; Ohtake T; Sugino T
BMC Cancer; 2015 Feb; 15():53. PubMed ID: 25884418
[TBL] [Abstract][Full Text] [Related]
13. GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
Huanna T; Tao Z; Xiangfei W; Longfei A; Yuanyuan X; Jianhua W; Cuifang Z; Manjing J; Wenjing C; Shaochuan Q; Feifei X; Naikang L; Jinchao Z; Chen W
Mol Carcinog; 2015 Oct; 54(10):1159-71. PubMed ID: 24962947
[TBL] [Abstract][Full Text] [Related]
14. Sam68 up-regulation correlates with, and its down-regulation inhibits, proliferation and tumourigenicity of breast cancer cells.
Song L; Wang L; Li Y; Xiong H; Wu J; Li J; Li M
J Pathol; 2010 Nov; 222(3):227-37. PubMed ID: 20662004
[TBL] [Abstract][Full Text] [Related]
15. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
Kobayashi T; Tsuda H; Moriya T; Yamasaki T; Kikuchi R; Ueda S; Omata J; Yamamoto J; Matsubara O
Breast Cancer Res Treat; 2010 Oct; 123(3):733-45. PubMed ID: 20020198
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer.
Sum EY; Segara D; Duscio B; Bath ML; Field AS; Sutherland RL; Lindeman GJ; Visvader JE
Proc Natl Acad Sci U S A; 2005 May; 102(21):7659-64. PubMed ID: 15897450
[TBL] [Abstract][Full Text] [Related]
17. Characterization of LMX-1A as a metastasis suppressor in cervical cancer.
Liu CY; Chao TK; Su PH; Lee HY; Shih YL; Su HY; Chu TY; Yu MH; Lin YW; Lai HC
J Pathol; 2009 Oct; 219(2):222-31. PubMed ID: 19644956
[TBL] [Abstract][Full Text] [Related]
18. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
19. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of TXNIP leads to high proliferative activity and estrogen-dependent cell growth in breast cancer.
Park JW; Lee SH; Woo GH; Kwon HJ; Kim DY
Biochem Biophys Res Commun; 2018 Apr; 498(3):566-572. PubMed ID: 29524408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
